Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer

ClinicalTrials.gov ID: NCT00915018

Public ClinicalTrials.gov record NCT00915018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 2:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Two-Arm Study Of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel As First-Line Treatment For ErbB-2-Positive Locally Recurrent Or Metastatic Breast Cancer

Study identification

NCT ID
NCT00915018
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Puma Biotechnology, Inc.
Industry
Enrollment
479 participants

Conditions and interventions

Conditions

Interventions

  • Neratinib Drug
  • Paclitaxel Drug
  • Trastuzumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 20, 2009
Primary completion
Jul 31, 2013
Completion
Jun 27, 2018
Last update posted
Aug 21, 2018

2009 – 2018

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Ventura County Hematology-Oncology Specialists Oxnard California 93030
Redwood Regional Medical Group Santa Rosa California 95403
Cancer Center of Central Connecticut Plainville Connecticut 06062
Palm Beach Institute of Hematology and Oncology Boynton Beach Florida 33435
North Broward Medical Center Cancer Center Deerfield Beach Florida 33064
Broward General Medical Center Fort Lauderdale Florida 33316
Mid Florida Cancer Centers Orange City Florida 32763
Florida Cancer Research Institute Plantation Florida 33324
Hematology Oncology Associates of Treasure Coast Port Saint Lucie Florida 34952
Phoebe Cancer Center Albany Georgia 31701
Dublin Hematology and Oncology Care Dublin Georgia 31021
Clintell Skokie Illinois 60077
Presence Hematology and Oncology Skokie Illinois 60077
Springfield Clinic Springfield Illinois 62703
CHRISTUS St. Frances Cabrini Hospital Alexandria Louisiana 71301
Hematology Oncology Services Metairie Louisiana 70006
Park Nicollet Institute Saint Louis Park Minnesota 55426
Missouri Cancer Associates Columbia Missouri 65201
St. John's Medical Research Institute Springfield Missouri 65807
Washington University School of Medicine Siteman Cancer Center St Louis Missouri 63110
The Valley Hospital, Luckow Pavilion Office of Oncology Clinical Trials Paramus New Jersey 07652
Gaston Hematology and Oncology Associates Gastonia North Carolina 28054
Summa Health System Hospitals Akron Ohio 44304-1619
Warren Cancer Research Foundation Tulsa Oklahoma 74104
Samaritan Hematology and Oncology Consultants Corvallis Oregon 97330
Pawtucket Memorial Hospital Pawtucket Rhode Island 02860
Medical University of South Carolina Hollings Cancer Center Charleston South Carolina 29425
Santee Hematology Oncology Sumter South Carolina 29150
Tenessee Cancer Specialists Knoxville Tennessee 37909
Family Cancer Care Memphis Tennessee 38120
Texas Oncology Bedford Texas 76022
El Paso Cancer Treatment Center El Paso Texas 79902
Texas Oncology-Allison Cancer Center Midland Texas 79701
Southlake Oncology Southlake Texas 76092
Utah Cancer Specialists Salt Lake City Utah 84106
Charleston Area Medical Center, Health, Education, and Research Institute Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 159 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00915018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2018 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00915018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →